Arginyl-Glutamine (TFA)

• Description :

  Arginyl-Glutamine TFA is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy[1].

• Product Name Alternative :

  H-Arg-Gln-OH (TFA)

• UNSPSC :

  12352209

• Target :

  VEGFR

• Related Pathways :

  Protein Tyrosine Kinase/RTK

• Field of Research :

  Cardiovascular Disease

• Purity :

  99.22

• Smiles :

  N=C(N)NCCC[C@H](N)C(N[C@H](C(O)=O)CCC(N)=O)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

• Molecular Formula :

  C17H25F9N6O10

• Molecular Weight :

  644.40

• References & Citations :

  [1]Neu J, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006 Jul;47 (7) :3151-5.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported